NAS10028,436+0.18%S&P7,613+0.44%GOLD$3,975+1.95%BTC$77,056−1.52%VIX19.75+1.70%latest tape · as of 18:19 UTC
The Screen · Financials · Banks - Regional
Credicorp Ltd.
BAP · the NYSE · USD · Market cap $27.7B · 51,509 employees
Credicorp Ltd., together with its subsidiaries, provides various banking services and products in Peru, Bermuda, Colombia, Bolivia, Panama, Chile, the United States, the Cayman Islands, and Mexico.
FAIL · Does not pass the screen
348.96 USD
Price as of 30 Oct 2026Daily close, not a live quote
Screened 2026-10-30 · the tape above runs as of 18:19 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Positioning no disclosures inside 60 days, left as found
Options put/call open interest 1.01, read 2026-10-29
Ethical does not pass the values gate
Price348.96 USD
Fair value481.82
Ethical score30.0/100
RatingAVOID
Our investment reviews on this name
2026-10-27Read Distribution390.26-10.6% to today ✓Accumulation gives way to Distribution
2026-10-02Read Accumulation385.95-9.6% to today Distribution gives way to Accumulation while volume is distributing
2026-08-22Read Distribution378.97-7.9% to today ✓Markup gives way to Distribution with volume flow in agreement
2026-07-02Read Markup369.55-5.6% to today First review on file: Markup
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Credicorp Ltd. holds its Distribution at $348.96. The statistical read favours the sellers, held for 6 days.
As held on the ledger · 2026-10-30
Phase
Distribution · caution
Quantitative state
The statistical read favours the sellers, held for 6 days
Price at the screen
$348.96
Valuation
13.14 trailing · 10.19 forward price to earnings
Values screen
FAIL· score 30.0
Beta
0.87
The Workings
Five Screens, Shown in Full
Does not pass. Business activity
Test
Figure
Limit
What it means
Status
Business activity
Excluded
Core business clean
Financial sector: banks
Fail
Debt load
0.00%
Below 33%
Interest-bearing debt is just 0.0% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
0.00%
Below 49%
Money owed to the company is 0.0% of assets, under the 49% limit.
Pass
Revenue purity
82.73%
Below 5%
82.7% of revenue comes from non-compliant sources, over the 5% line.
Fail
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
Credicorp does not clear the screen at the business-activity stage. It operates in conventional financial services, which the screen treats as interest-based, so the financial ratios are not the deciding factor here.
Read as at 2026-11-01. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when BAP's ethical verdict changes
Today BAP does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
What the Numbers Say It Is Worth
The Fair Value Range
Our analysis reads AVOID: it trades at roughly a 38% discount to our $481.82 fair value, moderate competitive moat, 12.00% revenue growth.
Fair value range in USD, drawn from the 2026-10-30 screen. The gold marker is the market price at the same screen. A 38.1% margin of safety to the base estimate.
Where our models see it going: fair-value estimate $481.82, with a range of $385.23 to $642.05, dated to the 2026-10-30 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Peruvian bank clears metrics yet fails ethics
Picture a regional lender moving money across Peru and a few neighbours. It looks steady enough on the surface. We pass on Credicorp because the ethical screen rules it out on business activity, full stop.
Revenue is growing 26 percent, margins sit at 33 percent and return on equity reaches 19 percent. Forward earnings trade at 11.6 times with a moderate moat. Those figures explain the buy ratings from thirteen analysts, yet none of it moves the ethical verdict.
Currency swings, political noise in Peru and the usual banking cyclicality add real downside. The modest margin of safety versus our fair value does not change the screen result. Analysis, not advice.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: its business and earnings are exposed to Peru and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
BAP trades on the NYSE (the company is based in Peru). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The framework has shifted from accumulation to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 8% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 64%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (14 analysts) rates it buy, with a mean price target of $427.
2026-10-20Accumulation$390.26+2.4%Entry 8
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 2.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 15% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 64%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (14 analysts) rates it buy, with a mean price target of $427.
2026-10-13Accumulation$381.21-1.2%Entry 7
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 1.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 19% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 64%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (14 analysts) rates it buy, with a mean price target of $427.
The framework has shifted from distribution to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 1.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 19% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 64%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (14 analysts) rates it none, with a mean price target of $427.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 3.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 19% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 64%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (13 analysts) rates it buy, with a mean price target of $391.
2026-07-22Markup$390.58+5.7%Entry 4
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 5.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 19% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 64%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (13 analysts) rates it buy, with a mean price target of $391.
2026-07-18Markup$369.55+0.0%Entry 3
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 19% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 64%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (13 analysts) rates it buy, with a mean price target of $391.
2026-07-03Markup$369.55+0.0%Entry 2
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns.
2026-07-02Markup$369.55Entry 1
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
